Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q4

Farmakoekonomika

IRBIS LLC

Russian FederationHealth Policy (Q4); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)ISSN-matched source record
Submission information ↗
Q4Ranking
—Impact Factor (year unverified)
11H-index (SCImago 2025)
0.159SJR (2025)
2017-2025Coverage

About Farmakoekonomika

Farmakoekonomika is a scholarly journal published by IRBIS LLC. SCImago 2025 lists it in Q4, with an SJR of 0.159 and H-index of 11.

Coverage: 2017-2025. Research categories: Health Policy (Q4); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2022-10-23. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesRussian
Licence optionsCC BY-NC-SA
Peer-review processDouble anonymous peer review
APCDOAJ-reported APC: 15000 RUB
Waiver policy reportedNo
Other fees reportedNo
Author retains unrestricted copyrightYes
Reported submission-to-publication time8 weeks on average; not a guarantee
Openly licensed content since2012 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2070-4909, 2070-4933
ISSN-L2070-4909
Source typeJournal
Publisher / hosting organisationIrbis (Czechia)
Publisher country codeRU
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex510
Citations recorded in OpenAlex1,352
OpenAlex H-index15
Years represented in OpenAlex2015–2026 (not the founding or closing dates)

Topics in published research

Healthcare Systems and Public Health; Health Systems, Economic Evaluations, Quality of Life; Pharmaceutical Economics and Policy; Economic, Social, and Public Health Issues in Russia and Globally; Economic and Financial Impacts of Cancer; Artificial Intelligence in Healthcare and Education.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit